If you or someone you love is thinking about a cancer clinical trial, you may be wondering what really happens, how safe it is, and whether it’s worth it. This guide walks you step by step through what clinical trials are, who they’re for, what you can expect day to day, and how to decide if joining one fits your goals and values.
What Are Cancer Clinical Trials and Why Do They Matter?
Cancer clinical trials are carefully designed research studies that test new ways to prevent, find, diagnose, treat, or manage cancer and its side effects. Before any new cancer drug, device, or treatment approach is approved for wide use, it must go through clinical trials to make sure it is safe and effective.
If you join a trial, you are not a “test subject” in the casual sense — you are a patient receiving care under strict safety rules and close monitoring. Clinical trials follow detailed protocols, are overseen by ethics committees (Institutional Review Boards, or IRBs), and must meet standards set by agencies like the U.S. Food and Drug Administration (FDA).
Clinical trials are important because they:
- Help discover better, more effective, or less toxic cancer treatments
- Offer some patients access to cutting-edge therapies before they are widely available
- Improve our understanding of side effects, quality of life, and survivorship
- Help ensure new therapies are safe for diverse groups of people
For more background, you can explore:
Types of Cancer Clinical Trials
Not all cancer trials are about new chemotherapy or immunotherapy. Different trials focus on different parts of the cancer journey. You may be offered (or may seek out) a trial in one or more of these areas:
- Prevention trials: Study ways to lower the risk of developing cancer, such as medications, vaccines, vitamins, or lifestyle changes.
- Screening trials: Test methods to find cancer earlier, when it may be easier to treat (for example, new imaging or blood tests).
- Diagnostic trials: Look at better ways to confirm a diagnosis or define the exact type or stage of cancer.
- Treatment trials: Evaluate new drugs, combinations of drugs, surgery techniques, radiation approaches, immunotherapy, or targeted therapy.
- Quality of life / supportive care trials: Focus on easing symptoms, managing side effects, improving emotional well-being, and supporting daily functioning during and after treatment.
If you are living with cancer now, you are most likely to hear about treatment and quality of life trials, but prevention, screening, and diagnostic trials may matter to you and your family in the long term as well.
How Treatment Trials Are Organized: Phases Explained
Treatment clinical trials usually move through several “phases.” Each phase has a different goal and involves different numbers of people.
- Phase I:
- Small group of participants (often 20–80 people)
- Main goal: find a safe dose and identify common side effects
- You may hear terms like “dose-escalation” (gradually increasing the dose under careful monitoring)
- These trials are often for people who have already tried standard treatments
- Phase II:
- Larger group of people (often 100–300 participants)
- Main goal: see how well the treatment works against a specific cancer type
- Still closely watching for safety issues and side effects
- Phase III:
- Many participants, often hundreds or thousands, across multiple hospitals and sometimes countries
- Main goal: compare the new treatment to the current standard treatment to see which is better or if it’s at least just as good with fewer side effects
- Often randomized: you are assigned (by chance) to one of the treatment groups
- Phase IV:
- Happens after a treatment is approved and on the market
- Main goal: monitor long-term safety and rare side effects in a much larger population and over a longer time
When you’re considering a trial, it helps to ask, “Which phase is this?” because that gives you a sense of how much is known about the treatment and what the main focus of the study will be (safety vs. effectiveness vs. long-term outcomes).
Who Can Join? Understanding Eligibility Criteria
Every trial has a list of rules called eligibility criteria. These rules are not meant to exclude you unfairly; they exist to protect you and to make sure the results are scientifically meaningful.
Eligibility often depends on:
- Type of cancer: For example, breast cancer vs. lung cancer, or a very specific subtype.
- Stage of cancer: Early-stage vs. advanced or metastatic disease.
- Previous treatments: Which therapies you’ve already received and how you responded.
- Overall health and medical history: Heart, kidney, or liver function; other serious conditions; performance status (how active and independent you are).
- Specific tumor or genetic features: For example, a trial might require a certain mutation or biomarker in your cancer.
- Age and sometimes sex or menopausal status: Depending on the question being studied.
Before you’re enrolled, you’ll often go through a pre-screening process. This may involve:
- Review of your medical records and prior treatments
- Blood work and imaging
- Sometimes special tests (like genetic or biomarker testing) on your tumor
If you’re interested in a trial, you can say to your team, “Can you check if I meet the eligibility criteria for this study?” Your oncologist or a research nurse can walk you through that process.
Is a Clinical Trial Right for You?
Deciding whether to join a trial is very personal. You’re not just choosing a treatment; you’re choosing a care pathway with specific visits, tests, and unknowns.
You may find it helpful to consider:
- Your treatment goals:
- Are you hoping for the longest possible survival, the best quality of life, fewer side effects, or a chance to avoid certain treatments (like chemotherapy)?
- Ask your doctor, “How does this trial fit with my specific goals?”
- How the trial compares to standard care:
- What would your treatment look like without the trial?
- Is the trial adding a new drug on top of standard therapy, replacing standard therapy, or testing a completely new approach?
- A second opinion at a major cancer center can help you weigh options, especially if you have a rare cancer.
- Practical issues:
- How often will you need to come in for visits, scans, or blood draws?
- Can you realistically manage the travel, time off work, or caregiving responsibilities?
- Is there financial support for travel or lodging (some trials and foundations can help)?
- Your comfort with uncertainty:
- Are you okay with a treatment that is promising but not yet proven?
- How do you feel about not knowing in advance which treatment arm you’ll receive?
As you think this through, it’s completely appropriate to ask detailed questions, take notes, and bring a family member or friend to appointments.
The Informed Consent Process
Informed consent is not just a signature on a form — it’s an ongoing conversation. Before you join a trial, the research team will explain in plain language:
- Why the study is being done and what it’s trying to find out
- Exactly what treatments, tests, and procedures you will receive
- How often you’ll need to come for visits and how long the study will last
- Known risks and side effects, and what is still unknown
- Potential benefits (to you and to future patients)
- Other treatment options outside of the trial
- How your privacy and medical data will be protected
- Your right to leave the trial at any time, for any reason
You should feel free to ask for more time, ask them to repeat or re-explain anything, or take the consent form home to review. You can say, “Can you walk me through what a typical month on this trial would look like for me?”
For more on informed consent, see:
What to Expect When You Participate in a Cancer Clinical Trial
Once you decide to join, here’s what the process usually looks like from your point of view.
Before You Start Treatment
Before receiving the study treatment, you will go through a screening or baseline period, which may include:
- Physical exam and detailed medical history
- Blood and urine tests
- Imaging studies (CT, MRI, PET scans, or ultrasounds)
- Possibly a biopsy or repeat biopsy
- Questionnaires about your symptoms, mood, and daily activities
These tests confirm that you meet the eligibility criteria and provide a “starting point” to compare against as the trial goes on.
During the Trial
Day to day, being on a trial often feels similar to getting regular cancer care, but with more structured monitoring. You can usually expect:
- Regular visits: These might be weekly, every few weeks, or at another schedule depending on the protocol.
- Ongoing tests: Blood tests, scans, and possibly heart or lung function checks to see how you’re responding and to look for side effects.
- Questionnaires: About symptoms, side effects, mood, sleep, and your ability to do daily activities. This is especially true for quality-of-life trials.
- Close monitoring: The research team watches carefully for any adverse effects and may adjust doses, delay treatment, or stop the study medication if needed for your safety.
Your care team usually includes your oncologist, research nurses, study coordinators, and sometimes pharmacists and social workers. You can and should report side effects early — often they can be managed better if addressed quickly.
After the Trial or If You Choose to Leave
You can leave a trial at any time. If you choose to stop:
- Your team will talk with you about next treatment options outside the trial.
- They may ask to keep following your health for a period of time (with your permission) to complete the study data.
- Your decision to leave will not affect your right to receive good standard cancer care.
Potential Benefits and Risks of Joining a Clinical Trial
Possible Benefits
- Access to new treatments: You may receive a promising new drug or therapy before it is widely available.
- Enhanced monitoring: More frequent visits, tests, and contact with the healthcare team can sometimes catch problems earlier.
- Contribution to science and future care: Your participation helps improve treatments for future patients — including possibly your own family members.
- Sometimes better outcomes: In some cases, the new treatment turns out to be more effective or less toxic than standard care, although this is never guaranteed.
Possible Risks
- Side effects: The treatment may cause mild to serious side effects. Some may be unknown or less predictable than with standard treatments.
- Ineffective treatment: The new approach may not work as well as hoped, or might not work for you personally.
- More visits and procedures: Extra blood draws, scans, biopsies, or questionnaires can be tiring and time-consuming.
- Randomization and placebo: In some trials, you are randomly assigned to receive the new treatment or standard treatment. Placebos alone are rarely used in cancer trials unless there is no established effective treatment; more often, a placebo is added to standard care.
Weighing the Pros and Cons for Yourself
When you are thinking it over, you might ask your care team:
- “What are the realistic best and worst case scenarios for me on this trial?”
- “If I don’t join, what is my best standard treatment option?”
- “How might this study affect my day-to-day life?”
- “If my cancer grows while on the trial, what happens next?”
It can help to talk with family, friends, other patients, or a counselor. Many people find it reassuring to know they are making an informed, thoughtful decision, no matter which path they choose.
Finding and Enrolling in a Cancer Clinical Trial
If you’re interested in exploring trials, you do not have to do it alone. Here are practical steps you can take.
Step 1: Talk With Your Healthcare Team
- Ask your oncologist if there are trials available at your treatment center that fit your situation.
- If there are none locally, ask, “Are there trials at regional or national cancer centers that might be right for me?”
- Request a referral if you’re open to traveling for a consultation.
Step 2: Use Reputable Online Trial Finders
Several trusted databases can help you search for trials:
- ClinicalTrials.gov – Comprehensive registry of trials around the world.
- NCI’s Clinical Trials Search – Cancer-focused and patient-friendly filters.
You can search by cancer type, stage, location, and other details. When you find a trial that looks promising, bring the trial ID (NCT number) to your oncologist and ask, “Could this be appropriate for me?”
Step 3: Go Through Screening and Enrollment
If a trial looks like a match:
- Pre-screening: The research team reviews your records and may order tests to see if you meet the basic criteria.
- Screening visits: If you qualify, you’ll have more detailed testing to confirm eligibility.
- Informed consent: You review and sign the consent form once all your questions are answered.
- Start of treatment: You are officially enrolled and begin the study treatment according to the trial schedule.
Remember: saying “yes” to screening does not commit you to joining the trial. You can opt out at any time before (or after) enrollment.
Equity, Diversity, and Your Voice in Research
Historically, some groups — including people from racial and ethnic minority communities, older adults, people in rural areas, and those with limited financial resources — have been underrepresented in cancer clinical trials. This means treatments may not have been tested as thoroughly in all the people who will eventually use them.
If you are from an underrepresented group, your participation can be especially powerful. It helps make sure that new treatments are safe and effective for everyone. You also have the right to:
- Receive clear information in a language you understand
- Have your cultural and personal values respected
- Ask about transportation help, financial counseling, or other support services
Many cancer centers now have navigators or social workers to support you through the process.
Frequently Asked Questions
What should I expect emotionally when joining a clinical trial?
It’s very normal to feel a mix of hope, anxiety, and uncertainty. Some people feel empowered by helping advance research, while others worry about the unknowns. You may have more appointments than usual, which can be tiring. Talking openly with your care team, loved ones, and possibly a counselor or support group can help you cope with these emotions and feel more in control of your choices.
What kinds of treatments are tested in cancer clinical trials?
Cancer clinical trials can test many types of treatments, including:
- Chemotherapy and new drug combinations
- Immunotherapy (helping your immune system fight cancer)
- Targeted therapies aimed at specific mutations or proteins
- Hormone therapies
- Radiation techniques and surgery approaches
- Supportive care treatments to improve symptoms or quality of life
Often, new treatments are combined with current standard therapies, rather than replacing them completely.
Will I receive a placebo instead of real treatment?
In cancer trials, it is rare for someone to receive only a placebo when an effective standard treatment exists. More commonly:
- Everyone receives at least standard treatment, and some participants receive an additional new drug or approach.
- A placebo may be used along with standard therapy so that neither patients nor doctors know who is getting the new treatment vs. the placebo (this helps prevent bias).
If there is no proven effective standard treatment for your situation, a placebo might be used alone in some cases, but this will be clearly explained in the consent form. You can always ask, “What treatment will I receive if I’m in the control group?”
How safe are cancer clinical trials?
No medical treatment is completely risk-free, and that includes clinical trials. However, trials are tightly regulated to protect you. Safety measures include:
- Approval and regular review by an Institutional Review Board (IRB)
- Predefined rules about when to change doses, pause, or stop the study
- Frequent monitoring of side effects and lab results
- Independent data monitoring committees, especially in large Phase III trials
If serious safety concerns arise, the trial may be modified or stopped early. Your personal doctor can also remove you from the study if it is no longer in your best interest.
Will it cost me more to be in a clinical trial?
Costs vary by study and by country. Usually:
- The trial sponsor (such as a drug company or research organization) pays for the study drug and extra research-related tests.
- Your usual care costs (standard tests, hospital stays, doctor visits) are often billed to you or your insurance as they would be outside a trial.
Before you enroll, ask to speak with a financial counselor or research coordinator. They can help you understand which costs are covered, whether there is help for travel or lodging, and what your insurance is likely to pay. You can also review NCI’s guide to paying for clinical trials for more detail.
What should I ask my doctor before deciding to participate?
You might ask:
- “What is the main purpose of this trial for someone in my situation?”
- “What are my options if I don’t join?”
- “What side effects are most common with this treatment?”
- “How often will I need to come in, and for how long?”
- “If this treatment doesn’t work for me, what are my next steps?”
Bringing a written list of questions and a support person to your appointment can make it easier to remember what you hear and feel confident in your decision.
